INS and diabetes mellitus: Chronic ABA treatment, started before diabetes induction, improves the glycemic profile in treated mice compared with untreated controls during a 28-day period (Figure 1A), without a significant difference between the groups’ plasma insulin levels after a final OGTT, and with similar residual amounts of pancreatic insulin mRNA at the end-point.